| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YPMED.2009.04.014 |
| P698 | PubMed publication ID | 19410600 |
| P50 | author | Vaughn Barry | Q89494335 |
| Elizabeth T Golub | Q112652360 | ||
| David Vlahov | Q44431641 | ||
| Don C Des Jarlais | Q59824152 | ||
| P2093 | author name string | Richard S Garfein | |
| Deborah Holtzman | |||
| Sharon M Hudson | |||
| Lawrence J Ouellet | |||
| P2860 | cites work | Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program | Q60358363 |
| Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City | Q64129844 | ||
| The use of needle exchange by young injection drug users. | Q64927111 | ||
| Incidence rate and risk factors for HCV seroconversion among injecting drug users in an area with low HIV seroprevalence | Q73277064 | ||
| Incidence and prevalence of hepatitis C among clients of a Brisbane methadone clinic: factors influencing hepatitis C serostatus | Q73320495 | ||
| Sharing of drug preparation equipment as a risk factor for hepatitis C | Q73466639 | ||
| HIV risk practices among needle exchange users and nonusers in Chicago | Q80471699 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Audio-computerized self-interviewing versus face-to-face interviewing for research data collection at drug abuse treatment programs | Q30938745 | ||
| Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. | Q31150012 | ||
| A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users | Q33256564 | ||
| Distributive syringe sharing among young adult injection drug users in five U.S. cities | Q33280696 | ||
| HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, Afghanistan | Q33800854 | ||
| Effectiveness of needle-exchange programmes for prevention of HIV infection | Q34742675 | ||
| Injecting alone among young adult IDUs in five US cities: evidence of low rates of injection risk behavior | Q36248852 | ||
| Changes in injection risk behavior associated with participation in the Seattle needle-exchange program | Q36272701 | ||
| Methadone treatment and HIV and hepatitis B and C risk reduction among injectors in the Seattle area | Q36272739 | ||
| Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004. | Q36440948 | ||
| The epidemiology of hepatitis C infection in the United States | Q36892181 | ||
| Prevalence, incidence, and correlates of chlamydia and gonorrhea among young adult injection drug users | Q37873480 | ||
| Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? | Q39634824 | ||
| Needle exchange and injection-related risk behaviors in Chicago: a longitudinal study | Q39795230 | ||
| Correlates of hepatitis C virus infections among injection drug users. | Q40453200 | ||
| The effect of syringe exchange use on high-risk injection drug users: a cohort study | Q41732202 | ||
| Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. The Northern Italian Seronegative Drug Addicts (NISDA) Study | Q42598808 | ||
| Validity of self-reported needle exchange attendance among injection drug users: implications for program evaluation | Q42667554 | ||
| Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users | Q42687175 | ||
| Syringe exchange and risk of infection with hepatitis B and C viruses | Q42691172 | ||
| Hepatitis C virus seroconversion among young injection drug users: relationships and risks | Q43041146 | ||
| Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco | Q43657708 | ||
| Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment | Q45733180 | ||
| Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT). | Q50154380 | ||
| Self reported risk behaviour among injecting drug users: self versus assisted questionnaire completion. | Q50803300 | ||
| Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year. | Q52266477 | ||
| Effectiveness of syringe exchange programs in reducing HIV risk behavior and HIV seroconversion among injecting drug users | Q56225840 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Hepatitis C virus | Q708693 |
| needle exchange programme | Q1760326 | ||
| P304 | page(s) | 68-73 | |
| P577 | publication date | 2009-05-04 | |
| P1433 | published in | Preventive Medicine | Q7242397 |
| P1476 | title | The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. | |
| P478 | volume | 49 |
| Q24629455 | A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs |
| Q34765207 | Age cohort differences in illicit drug use and hepatitis C among African American substance users |
| Q34077806 | Awareness of biologically confirmed HCV among a community residing sample of drug users in Baltimore City. |
| Q42619415 | Change in HIV-HCV risk-taking behavior and seroprevalence among opiate users seeking treatment over an 11-year period and harm reduction policy |
| Q59349570 | Combination interventions for Hepatitis C and Cirrhosis reduction among people who inject drugs: An agent-based, networked population simulation experiment |
| Q36629330 | Differing HIV risks and prevention needs among men and women injection drug users (IDU) in the District of Columbia. |
| Q33862919 | Ending hepatitis C in the United States: the role of screening. |
| Q36783216 | Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department |
| Q38020157 | Evolving epidemiology of hepatitis C virus in the United States |
| Q36101848 | Hepatitis C among Intravenous Drug Users in Isfahan, Iran: a Study of Seroprevalence and Risk Factors |
| Q37899936 | Hepatitis C virus infection in USA: an estimate of true prevalence |
| Q37671939 | Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission |
| Q36101876 | High risky behaviors among intravenous drug users in Isfahan, Iran: A study for hepatitis C harm reduction programs |
| Q49688967 | How outpatient substance abuse treatment unit director activities may affect provision of community outreach services |
| Q64117950 | Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol |
| Q28540278 | Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period |
| Q57178901 | Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention |
| Q36882030 | Injecting risk behavior among traveling young injection drug users: travel partner and city characteristics. |
| Q33846529 | Lessons learned from a peri-urban needle exchange |
| Q33702754 | Needle exchange programs for the prevention of hepatitis C virus infection in people who inject drugs: a systematic review with meta-analysis |
| Q40048259 | Needle syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. |
| Q42720607 | Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs |
| Q64293502 | PRO: Needle Exchange Programs Should Be Instituted to Reduce Hepatitis C Virus Transmission |
| Q39962371 | Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities |
| Q59354559 | Prevalence of hepatitis C virus in young people who inject drugs in four Colombian cities: A cross-sectional study using Respondent Driven Sampling |
| Q92488360 | Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs |
| Q53647794 | Reduction in Needle Sharing Among Seattle-Area Injection Drug Users Across 4 Surveys, 1994-2013. |
| Q57193075 | Strategies for the elimination of hepatitis C virus infection as a public health threat in the United States |
| Q88610873 | Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition |
| Q39653268 | Triangulating Syndemic Services and Drug Treatment Policy: Improving Drug Treatment Portal Locations in Baltimore City. |
| Q53223818 | Using Pharmacies in a Structural Intervention to Distribute Low Dead Space Syringes to Reduce HIV and HCV Transmission in People Who Inject Drugs. |
Search more.